文献速递肺外科

≤3 cm 伴不良病理特征的非小细胞肺癌亚肺叶切除的肿瘤学结局

Oncologic outcomes of sublobar resection in non-small cell lung cancer ≤3 cm with adverse pathologic features.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2026-10-13

本研究回顾性分析 2017 至 2023 年 1,774 例 cN0M0、病理肿瘤大小≤3 cm 的非小细胞肺癌患者,比较亚肺叶切除(666 例)与肺叶切除(1,108 例)的无复发生存。脉管侵犯、STAS 和高分级组织学独立与复发风险升高相关,而切除范围在多变量分析中未独立相关(HR 1.17,95%CI 0.69-1.98,p=0.562);倾向评分加权后各不良特征亚组的生存曲线基本重叠。

要点

  • 脉管侵犯、STAS 和高分级组织学独立与复发风险升高相关。
  • 多变量分析中肺叶切除与无复发生存无独立关联(HR 1.17,95%CI 0.69-1.98,p=0.562)。
  • 加权后各不良特征亚组的生存曲线基本重叠,但研究未设计证明两种术式等效。

核心结论

  • 脉管侵犯、STAS 和高分级组织学独立与复发相关,而切除范围未显示独立关联。
  • 加权分析未显示两种手术组间无复发生存曲线明显分离,但本研究未设计证明两种术式等效。

研究设计与样本

  • 回顾性队列研究,纳入 2017 至 2023 年接受根治性意向切除的 cN0M0 非小细胞肺癌、病理肿瘤大小≤3 cm 患者。
  • 共 1,774 例,其中亚肺叶切除 666 例,肺叶切除 1,108 例。
  • 采用 Cox 比例风险模型识别无复发生存相关因素,并使用倾向评分加权处理组间差异。

主要发现

  • 脉管侵犯、STAS 和高分级组织学独立与复发风险升高相关。
  • 多变量分析中肺叶切除与无复发生存无独立关联(HR 1.17,95%CI 0.69-1.98,p=0.562)。
  • 未调整亚组分析中,脉管侵犯、STAS 或高分级组织学患者的不同切除范围间无复发生存无显著差异(p>0.05),合并亚组结果相似。
  • 加权后基线失衡减少,但各不良特征亚组的生存曲线基本重叠。

临床怎么用

  • 对于≤3 cm 且伴脉管侵犯、STAS 或高分级组织学的 cN0M0 非小细胞肺癌,切除范围的选择需综合评估,不能仅依据不良病理特征推断肺叶切除更优。
  • 本研究未设计证明亚肺叶切除与肺叶切除等效,临床决策应结合患者具体情况并参考其他证据。

局限性

  • 本研究为回顾性分析,未设计证明两种手术方式的等效性。
  • 原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study evaluated the association between resection extent and recurrence-free survival in patients with clinically node-negative NSCLC ≤3 cm with adverse pathologic features including visceral pleural invasion, spread through air spaces (STAS), or high-grade histology. METHODS: We retrospectively reviewed patients who underwent curative-intent resection for cN0M0 NSCLC with pathologic tumor size ≤3 cm between 2017 and 2023. Patients were categorized into sublobar resection and lobectomy groups. Cox proportional hazards models were used to identify factors associated with recurrence-free survival. Propensity-score weighting was used to account for measured differences between the surgical groups, followed by weighted survival analyses within prespecified individual and combined adverse-feature subgroups. RESULTS: Among 1,774 patients, 666 underwent sublobar resection and 1,108 underwent lobectomy. Visceral pleural invasion, STAS, and high-grade histology were independently associated with a higher risk of recurrence. Lobectomy was not independently associated with recurrence-free survival in multivariable analysis (HR, 1.17; 95% CI, 0.69-1.98, p = 0.562). In unadjusted subgroup analyses, recurrence-free survival did not significantly differ by resection extent among patients with visceral pleural invasion, STAS, or high-grade histology with similar findings in combined subgroups (p > 0.05). Weighting reduced the baseline imbalances, while the resulting survival curves remained largely overlapping across the individual adverse-feature subgroups. CONCLUSIONS: Visceral pleural invasion, STAS, and high-grade histology were independently associated with recurrence, whereas resection extent was not. The weighted analysis did not show a clear separation between surgical groups, although the present analysis was not designed to demonstrate comparable efficacy between the two surgical approaches.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Yun T, Lee D, Park JH, et al. Oncologic outcomes of sublobar resection in non-small cell lung cancer ≤3 cm with adverse pathologic features. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 42867137. doi:10.1093/icvts/ivag263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。